Panel discussion: cell monitoring and imaging

REGISTER NOW

Tuesday 13 July 2021 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
Alternative time zones

This panel discussion, featuring experts from institutions across the world, will focus on the current landscape of cell monitoring and imaging for cell therapies. It aims to assess how researchers around the globe are utilizing cell monitoring and imaging techniques and will address the current challenges faced within the field. We will also discuss our experts’ predictions for how cell monitoring and imaging may evolve in the future.  

What will you learn?

  • The main cell properties and features of interest
  • The current technologies being used for this
  • The biggest challenges faced with cell monitoring and imaging techniques/technologies
  • How these technologies/techniques may evolve in the future  

Who may this interest?

  • Graduate students, researchers and clinicians working in the multidisciplinary field of cell therapy and regenerative medicine  
  • Individuals with an interest in cell monitoring and imaging for cell therapies
  • Regenerative medicine investors  

Speakers

Jake Boy
Senior Application Scientist
Scientific Bioprocessing (PA, USA) 

Jake earned his BA in Organismic and Evolutionary Biology at Harvard University (MA, USA). He has a professional background in research labs, genetics and cell culturing. As an Application Scientist at Scientific Bioprocessing, Jake supports new product development and testing and problem solves for each customer’s unique bio-application. Jake is dedicated to improving the science surrounding cell culture and helping customers attain their scientific goals. 

Tammy Kalber
Principle Research Fellow
University College London (UCL; UK)

Dr Kalber is a Principle Research Fellow at the Center for Advanced Biomedical Imaging (UCL). Her work centers on developing innovative imaging techniques using nanochemistry and molecular engineering to monitor cell therapies in vivo. In her work, Dr Kalber intends to correlate quantitative delivery and localization of cells, with the assessment of cell viability, in order to investigate the efficacy of cell therapies and predict their potential therapeutic outcomes.

Patricia Murray
Professor of Stem Cells and Regenerative Medicine
University of Liverpool (UK)

Patricia Murray is a Professor of Stem Cells and Regenerative Medicine at the Institute of Translational Medicine (Liverpool, UK). Her current research includes investigating the safety and efficacy of regenerative medicine therapies for renal and other diseases and exploring the underlying mechanisms of action. To this end, she works with chemists and imaging physicists at Liverpool to develop novel imaging probes and multi-modal imaging strategies to monitor the biodistribution and fate of the administered cell therapies and determine their ability to improve renal function and architecture.

 

In association with